Yazan Alwarawrah

2012-2016 Pharmacology Duke University, Durham, NC 
"Yazan Alwarawrah"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kulkarni MM, Ratcliff AN, Bhat M, et al. (2017) Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology. 14: 45
Spector NL, Haystead T, Zhao S, et al. (2017) Abstract 2219: Cancer prevention using a novel fatty acid synthase inhibitor Cancer Research. 77: 2219-2219
Alwarawrah Y, Hughes P, Loiselle D, et al. (2016) Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer. Cell Chemical Biology
Darr D, Alwarawrah Y, Hunter L, et al. (2015) Abstract 4457: Novel fatty-acid synthase inhibitor in combination with platinum-based therapy provides increased tumor killing efficacy in luminal breast murine model Cancer Research. 75: 4457-4457
Alwarawrah Y, Hughes P, Safi R, et al. (2015) Abstract 2703: Overcoming Lapatinib resistance by the fatty acid synthase inhibitor HS-106 Cancer Research. 75: 2703-2703
Howe MK, Bodoor K, Carlson DA, et al. (2014) Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chemistry & Biology. 21: 1648-59
See more...